n-sulfo-2-aminotricarballylate has been researched along with calcium phosphate, monobasic, anhydrous in 1 studies
| Studies (n-sulfo-2-aminotricarballylate) | Trials (n-sulfo-2-aminotricarballylate) | Recent Studies (post-2010) (n-sulfo-2-aminotricarballylate) | Studies (calcium phosphate, monobasic, anhydrous) | Trials (calcium phosphate, monobasic, anhydrous) | Recent Studies (post-2010) (calcium phosphate, monobasic, anhydrous) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 1,838 | 62 | 36 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheung, HS; Misra, RP; Nair, D; Sallis, JD | 1 |
1 other study(ies) available for n-sulfo-2-aminotricarballylate and calcium phosphate, monobasic, anhydrous
| Article | Year |
|---|---|
Phosphocitrate inhibits a basic calcium phosphate and calcium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal transduction pathway.
Topics: Calcium Phosphates; Calcium Pyrophosphate; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cells, Cultured; Citrates; Crystallization; Cyclic AMP Response Element-Binding Protein; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Interleukin-1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Mas; Signal Transduction; Tricarboxylic Acids | 1997 |